Skip to main content

COVID-19 Topic Center

Interview

Interview
Lissy Hu, founder and CEO of CarePort, discussed the importance of collaboration between providers, main challenges with care coordination, and shares how CarePort facilitates collaboration through a large network and real-time patient tracking.
Interview
Frank Jackson, vice president and general manager of health language, Wolters Kluwer, emphasizes the importance of using the correct health language to improve processes for physicians and patients, as well as explains how to solve challenges faced by payers by utilizing the latest technology and…
Interview
Joshua M. Liao, MD, MSc, board-certified internal medicine physician, Principal Scientist in the Value & Systems Science Lab, and medical director of Payment Strategy at UW Medicine, discusses the findings of his recent study that examined baseline episode spending patterns for safety-net…
Interview
Han-Zhu Qian, MD, PhD, MPH, explains the importance of screening cognitive functions and identifying the domains of cognitive impairment by age group among people living with HIV.
Interview
Michael Drummond PhD, Professor of Health Economics, University of York, UK, and Allen Lising, Managing Director of FormularyDecisions, a part of AmerisourceBergen, offer insight from their recent study which assessed the current use of cost-effectiveness analyses in decision-making for the…
Interview
Diane Smith, PhD, associate director of reimbursement…
Interview
Carmela Benson, director, real world value & evidence, Janssen Scientific Affairs, LLC, discusses recent research that examined Schizophrenia Population Health Management among adults in order to better understand how population health decision makers prioritize and respond to challenges in…
Interview
Annie Yan, PharmD, manager of value & access strategy at Xcenda, a part of AmerisourceBergen, offers insight from study that evaluated payer-initiated oncology pathways, in which trends in utilization, development, and barriers to implementation were measured.
Interview
Tasmina Hydery, PharmD, MBA, BCGP, assistant director, integrated technology solutions, and Linnea Tennant, PharmD, MBA, MS, assistant director, value and access strategy, both from Xcenda, discuss their recent study which examined the ICER value assessment framework, and its connection to trends…
Interview
Jenn Zerbato, PhD, post-doctoral research fellow, Peter Doherty Institute for Infection and Immunity, breaks down why HIV RNA could serve as a better measure of efficient latency reversal in both pre-clinical and clinical assessment of latency reversing agents.
Back to Top